Award of keratin biosciences' DHA sbir phase II medical R & D contract from proposal H2-0480 for "clinical evaluation of biocompatible dressings for the delivery of analgesics"
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH19C0171
- Awardee
-
Keranetics Inc. UEI MKUJS7WLH1S7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,070,533
Award facts
- Opportunity
-
- HQ003419R1ADB Solicitation number
- Contract value 100% obligated
- $1,070,532.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Winston-Salem, NC 27101, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,070,533 |
About this award
This is a $1,070,532.90 firm fixed-price SBIR Phase II research and development contract awarded by the U.S. Army Medical Command (MEDCOM) to Keranetics Inc., a small business based in Winston-Salem, North Carolina. The contract is for the "Clinical Evaluation of Biocompatible Dressings for the Delivery of Analgesics" and was awarded under solicitation H2-0480. Keranetics is developing its KeraStat gel technology to prevent scar contracture after burn injuries. This SBIR Phase II contract will support preclinical, regulatory, and manufacturing development activities for Keranetics' biocompatible wound dressing product. The contract has a period of performance through October 25, 2023.
Quick answers
Who was awarded contract W81XWH19C0171?
W81XWH19C0171 was awarded to Keranetics Inc. by Defense Health Agency (Department of Defense) on August 26, 2019.
How much is contract W81XWH19C0171 worth?
The government has obligated $1,070,533 on W81XWH19C0171.
Which agency awarded contract W81XWH19C0171?
Defense Health Agency (Department of Defense) awarded W81XWH19C0171, with funding from Medical Command (Department of the Army).
Was contract W81XWH19C0171 competed?
The extent of competition for W81XWH19C0171 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award